heisser als Internet in Asien......!!? - 500 Beiträge pro Seite

[Spyder]

hab heute von ´nem bekannten der recht nahe am geschehen sitzt einige infos bekommen. ist zwar ein langer text aber das lesen lohnt sich. zumal die aktie kurzfristig vom otc board an die amex wechseln soll.

ich hab mir mit 4,05 eine kleine startposition gekauft. wenn jemand weitere infos hat, besonders zum wechsel an die amex, habe ich grosses interesse....

hier die infos, die ich bekommen habe (die aktuellste meldung steht ganz unten):

___________________
MW Medical Announces Q4 Sales Increase of 1500% Over Q3 1999
Tuesday, January 11, 2000 06:01 AM

PHOENIX, Jan. 11 /PRNewswire/ -- MW Medical (OTC Bulletin Board: MWMD) announced today that
sales for the fourth quarter 1999 were strong and have exceeded the Company`s expectations. Jan Wallace, Chairman and President said, "We are very pleased with the initial reception and interest in our new product, the MW-2000, for cosmetic hair removal. Sales for the fourth quarter increased 1500% over Q3, 1999 showing a positive trend for the product and company." This level of sales activity for a new technology such as ours shows the strength of MW`s sales network, and that customers are not satisfied with the older technologies offered by other device companies, Wallace continued.

Wallace continued, "Our sales results are particularly exciting since they`re coming from a new product
in a highly competitive market. MW`s salesforce has been able to effectively differentiate the MW-2000
from all the other devices available to physicians for hair removal." The MW-2000 microwave technology
offers a unique solution for physicians to treat more skin types and hairs colors throughout the year,
capabilities even current laser and intense pulsed light modalities cannot provide.

Mitch DeShon, VP of Global Sales, stated, "MW`s challenges moving forward are building and shipping
our order backlog from Q4,1999 in the new quarter; building a solid clinical foundation so new users
can quickly adopt the technique and technology; and bringing out new cosmetic applications for
microwaves in the near future." The company currently has IRB protocol approvals for several new
clinical indications treatable with microwave energy.

MW Medical develops, manufactures and markets medical devices utilizing proprietary microwave
technologies for hyperthermic treatments in general and cosmetic hair removal in particular. In addition,
the company is investigating the use of microwave technologies for non-invasive treatment of varicose
veins and other benign vascular lesions.

Statement Under the Private Securities litigation Reform Act


With the exception of the historical information contained in this release, the matters described herein
contains forward-looking statements that involve risk and uncertainties that may individually or mutually
impact the matters herein described, including but not limited to product acceptance, economic,
competitive, governmental, results of litigation, technological and/or other factors, which are outside the
control of the Company.

SOURCE MW Medical


MW Medical Hires New Chief Operating Officer
Wednesday, January 12, 2000 06:01 AM

SCOTTSDALE, Ariz., Jan. 12 /PRNewswire/ -- MW Medical, Inc. (OTC Bulletin Board: MWMD) today
announced the appointment of Tyler Brown as Chief Operating Officer. Brown will be overseeing the
day-to-day operations of the company and brings with him extensive experience in operational
management, strategic development, product management and marketing.

This is a dynamic time for MW Medical, and we are pleased to be able to add Tyler`s experience to
our senior management team," said Jan Wallace, Chairman and CEO of MW Medical. "Tyler
understands what it takes to build an effective, industry-leading organization and he can provide the
leadership necessary for the long-term success of the company."

At MW Medical Brown will be responsible for the company`s product development, manufacturing,
customer support and marketing functions. Although headquartered in Scottsdale, AZ, MW Medical
has R&D and manufacturing facilities in California and subcontractors in multiple states. Wallace goes
on to state, "Tyler`s ability to lead groups and his history of bringing complex, multi-site projects to
successful fruition will be a significant advantage to MW Medical," said Wallace.

I am very pleased to be joining the MW Medical team," said Brown. "This technology is both exciting
and highly versatile. It definitely represents a unique advancement in the industry, and presents
physicians with an entirely new option for cosmetic applications. The potential for the company to use
the MW-2000 platform in multiple applications for the physician and consumer. I`m looking forward to
being a part of this company`s growth and development." MW Medical`s plan calls for multiple product
releases based on the MW-2000 microwave platform.

Brown has over 15 years of medical device marketing and product development experience. Most
recently Brown was Director of Marketing for ESC-Sharplan, a leading manufacturer of medical lasers
and intense pulse light devices for surgical and aesthetic applications. While at ESC-Sharplan, Brown
also spearheaded development and introduction of new products in the medical, aesthetic and
veterinary markets for the company. He also led ESC`s highly successful effort to bring new
technologies to non-aesthetic medical specialties. Prior to joining ESC-Sharplan, Brown held
marketing, product development and management positions with Advanced Technology Laboratories,
Data I/O Corporation and Sound Technology Corporation and Johnson & Johnson. Brown holds a
Masters of Business Administration from Pennsylvania State University and a BA from Ohio Wesleyan
University.

About MW Medical


MW Medical develops, manufactures and markets medical devices utilizing proprietary microwave
technologies for hyperthermic treatments in general and cosmetic hair removal in particular. In addition,
the company is investigating the use of microwave technologies for non-invasive treatment of varicose
veins and other benign vascular lesions.

Statement Under the Private Securities litigation Reform Act. With the exception of the historical
information contained in this release, the matters described herein contains forward-looking statements
that involve risk and uncertainties that may individually or mutually impact the matters herein
described, including but not limited to product acceptance, economic, competitive, governmental,
results of litigation, technological and/or other factors, which are outside the control of the Company.

SOURCE MW Medical, Inc.


MW Medical Trades on the Frankfurt Stock Exchange
Thursday, January 27, 2000 07:01 AM


SCOTTSDALE, Ariz., Jan. 27 /PRNewswire/ -- Jan Wallace, C.E.O., is pleased to announce that the
shares of MW Medical Inc. (OTC Bulletin Board: MWMD; Frankfurt) as of Jan. 14, 2000 are now
trading on the Frankfurt Stock Exchange.

MW Medical has many valued shareholders and investors in Germany, Austria, Switzerland, England
and Holland, and welcomes the increased distribution. The trading symbol of the shares on the
exchange is MWMD.F.

The company has always appreciated the tremendous support of its European partners, and is
constantly humbled by the efforts put forth, by them, for the company", states Jan Wallace, "The
listing on the Frankfurt Exchange will give them and the company an opportunity to expand its
shareholder base".

MW Medical patented microwave device is a multi-use platform for treating a broad range of cosmetic
applications, including hair removal, the treatment of spider veins and facial wrinkles.

The Company will be announcing further news concerning the expansion of our product and client base
throughout Europe within the first quarter.


MW Medical Announces New Patents for its MW 2000 Microwave Hair Removal
Device
Wednesday, February 2, 2000 07:01 AM


PHOENIX, Feb. 2 /PRNewswire/ -- MW Medical Inc. (OTC Bulletin Board: MWMD) announced this
week that the US Patent Office has issued two new patents for its microwave delivery system. The
technology is currently approved by the FDA for hair removal, and is being marketed to physicians in
the United States, and Internationally.

The patents describe the therapeutic uses of the device and features of the proprietary applicator used
in the system. The Company will continue to file new patents for its ongoing technological applications.
The MW 2000 uses microwave energy to thermally affect the hair follicle without damaging surrounding
tissue. Clinical trials in the US and Europe have proven the clinical efficacy of the system and its
introduction into the cosmetic market has been very well received. Microwave energy is not absorbed
by pigment in the skin which makes it safe for use on individuals of all skin types and colors -- this is
in contrast to laser therapies which can cause changes in pigmentation and scarring.

"MW Medical is committed to the research and development of definitive microwave technology," said
Jan Wallace, CEO of MW Medical, Inc. "Our entry into the cosmetic market with the MW 2000 device
provides physicians with a superior option for hair removal, and we are confident that the technology
will prove effective for a wide range of applications."

Based in Arizona, MW Medical is devoted to developing, manufacturing, and marketing advanced
microwave technology use by physicians worldwide. For more information about MW Medical call (480)
315-8600, or visit www.mwmd.com.

Statement Under the Private Securities Litigation Reform Act


With the exception of the historical information contained in this release, the matters described herein
contain forward-looking statements that involve risk and uncertainties that may individually or mutually
impact the matters herein described, including but not limited to product acceptance, economic,
competitive, governmental, results of litigation, technological and/or other factors, which are outside the
control of the Company.

SOURCE MW Medical Inc.

[Spyder]

es läuft.... +9% in frankfurt.....